Angelique Barreto, MD is a clinical research site located in Oklahoma City, Oklahoma, United States 73134.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Angelique Barreto, MD has participated in 2 clinical trials.
Therapeutic areas: Diabetic Neuropathy, Painful, Partial Seizures, Epilepsies, Partial.
Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oklahoma · View every site in Oklahoma City
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Angelique Barreto, MD has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Angelique Barreto, MD has 2 clinical trials on record. Their work covers Diabetic Neuropathy, Painful, Partial Seizures, Epilepsies, Partial.
Angelique Barreto, MD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.